Neutral Torrent Pharma; target of Rs 4300: Motilal Oswal
Neutral Torrent Pharma; target of Rs 4300: Motilal Oswal is drawing significant interest across the industry.
Motilal Oswal recommended Neutral rating on Torrent Pharma with a target price of Rs 4300 in its research report dated February 14, 2026.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Westmoreland happenings: Fly-tying workshop, soup sale, meetings, more
- Violence erupts on sidelines of children's football match as footage shows parents 'throwing punches'
- Affordable Ways to Upgrade Your Home’s Aesthetic
- ACIP panel may postpone meeting, latest sign of CDC dysfunction
Source: Original →